Neutralization of SARS-CoV-2 Variants by rVSV-ΔG-Spike-Elicited Human Sera

The emergence of rapidly spreading variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses a major challenge to the ability of vaccines and therapeutic antibodies to provide immunity. These variants contain mutations of specific amino acids that might impede vaccine efficacy....

Descripción completa

Detalles Bibliográficos
Autores principales: Yahalom-Ronen, Yfat, Erez, Noam, Fisher, Morly, Tamir, Hadas, Politi, Boaz, Achdout, Hagit, Melamed, Sharon, Glinert, Itai, Weiss, Shay, Cohen-Gihon, Inbar, Israeli, Ofir, Izak, Marina, Mandelboim, Michal, Caraco, Yoseph, Madar-Balakirski, Noa, Mechaly, Adva, Shinar, Eilat, Zichel, Ran, Cohen, Daniel, Beth-Din, Adi, Zvi, Anat, Marcus, Hadar, Israely, Tomer, Paran, Nir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879449/
https://www.ncbi.nlm.nih.gov/pubmed/35214749
http://dx.doi.org/10.3390/vaccines10020291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879449/
https://www.ncbi.nlm.nih.gov/pubmed/35214749
http://dx.doi.org/10.3390/vaccines10020291

Ejemplares similares